ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CANCER INHIBITION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
Fluorous synthesis: A fluorous-phase strategy for improving separation efficiency in organic synthesis
DOI 10.1126/science.275.5301.823
Armido S, Sabine H, Rafael F, Sun-Young Kim, Patrick J, Piter W, Curran DP (1997) Fluorous synthesis: A fluorous-phase strategy for improving separation efficiency in organic synthesis. Science 275:823-826. doi:10.1126/science.275. 5301.823 (Pubitemid 27074881)
In vitro, and in vivo, evaluation of dihydropyrimidinone C-5 amides as potent and selective α(1A) receptor antagonists for the treatment of benign prostatic hyperplasia
DOI 10.1021/jm990612y
Barrow JC, Nantermet PG, Slenick HG (2000) In vitro and in vivo evaluation of dihydropyrimidinone c-5 amides as potent and selective a1a receptor antagonists for the treatment of benign prostatic hyperplasia. J Med Chem 43:2703-2718. doi:10.1021/ jm990612y (Pubitemid 30463919)
Design and synthesis of a conformationally rigid mimic of the dihydropyrimidine calcium channel modulator SQ 32,926
Birgit J, Tetiana P, Kappe CO (2000) Design and synthesis of a conformationally rigid mimic of the dihydropyrimidine calcium channel modulator SQ. Molecules 5:227-239. doi:10.3390/50300227 (Pubitemid 39016385)
1,4-Dihydropyridines as antagonists of platelet activating factor 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives
doi:10.1021/jm000 95a005
Cooper K, Fray MJ, Parry MJ, Richardson K (1992) 1,4-Dihydropyridines as antagonists of platelet activating factor 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives. J Med Chem 35:3115-3129. doi:10.1021/jm000 95a005
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
DOI 10.1126/science.1077215
Deres K, Schroder CH, Paessens A, Goldmann S, Hecker HJ (2003) Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299:893-896. doi:10.1126/ science.1077215 (Pubitemid 36182448)
An efficient one-pot synthesis of dihydropyrimidinones by a samarium diiodide catalyzed biginelli reaction under solvent-free conditions
DOI 10.1002/ejoc.200400753
Han XY, Xu F, Luo YQ, Shen Q (2005) An efficient one-pot synthesis of dihydropyrimidinones by a samarium diiodide catalyzed Biginelli reaction under solvent-free conditions. Eur J Org Chem 8:1500-1503. doi:10.1002/ejoc.200400753 (Pubitemid 40633433)
Exploring QSAR fundamentals and applications in chemistry and biology. ACS Washington Kappe CO (1993) 100 years of the Biginelli dihydropyrimidine synthesis
doi:10.1016/S0040-4039 (02)01626-X
Hansch C, Leo A (1995) Exploring QSAR, fundamentals and applications in chemistry and biology. ACS, Washington Kappe CO (1993) 100 years of the Biginelli dihydropyrimidine synthesis. Tetrahedron 49:6937-6963. doi:10.1016/S0040-4039 (02)01626-X
4-Aryldihydropyrimidines via the Biginelli condensation: Aza-analogs of nifedipine-type calcium channel modulators
Kappe CO (1998) 4-Aryldihydropyrimidines via the Biginelli condensation: Aza-analogs of nifedipine-type calcium channel modulators. Molecules 3:1-9. doi:10.3390/30100001 (Pubitemid 39146470)
Recent advances in the Biginelli dihydropyrimidine synthesis. New tricks from an old dog
doi:10.1021/ar000048h
Kappe CO (2002) Recent advances in the Biginelli dihydropyrimidine synthesis. New tricks from an old dog. Acc Chem Res 33:879-888. doi:10.1021/ar000048h
X-ray structure, conformational analysis, enantioseparation, and determination of absolute configuration of the mitotic kinesin Eg5 inhibitor monastrol
DOI 10.1016/S0040-4020(00)00116-2, PII S0040402000001162
Kappe CO, Uray G, Verdino P, Shishkin OV (2000) X-ray structure, conformational analysis, enantioseparation, and determination of absolute configuration of the mitotic kinesin Eg5 inhibitor monastrol. Tetrahedron 56:1859-1862. doi:10.1016/S0040-4020 (00)00116-2 (Pubitemid 30176427)
(2000)Tetrahedron, vol.56, Issue.13, pp. 1859-1862
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
doi:10.1093/jnci/83.11.757
Monks A, Scudiero D, Skehan PR, Schoemaker K, Paull D, Vistica C (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83:757-766. doi:10.1093/jnci/83.11.757
Biomimetic synthesis of (+)-crambines A, B, C1, and C2. Revision of the structure of crambines B and C1
doi:10.1021/jo00067a014
Snider BB, Shi Z (1993) Biomimetic synthesis of (+)-crambines A, B, C1, and C2. Revision of the structure of crambines B and C1. J Org Chem 58:3828-3839. doi:10.1021/jo00067a014
Discovery and SAR of cyclic isothioureas as novel NPY Y1 receptor antagonists
doi:10.1016/j.bmcl.2009.09.048
Sun ZY, Zhu Z, McKittrick B (2009) Discovery and SAR of cyclic isothioureas as novel NPY Y1 receptor antagonists. Biorg Med Chem Lett 19:6801-6805. doi:10.1016/j.bmcl.2009.09.048
New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity
Weislow OW, Kiser R, Fine D, Bader J, Shoemaker RH, Boyd MR (1989) New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81:577-586. doi:10.1093/jnci/81.8.577 (Pubitemid 19104488)
Brønsted acidic ionic liquid: An efficient and reusable catalyst for the synthesis of 3,4-dihydropyrimidin- 2(1H)-ones
doi: 10.1080/00397910600588488
Zheng R, Wang X, Xu H, Du J (2006) Brønsted acidic ionic liquid: An efficient and reusable catalyst for the synthesis of 3,4-dihydropyrimidin- 2(1H)-ones. Syn Commun 36:1503-1513. doi: 10.1080/00397910600588488
